Abstract
Over the last decade, danger-associated molecular pattern molecules, or alarmins, have been recognized as signaling mediators of sterile inflammatory responses after trauma and injury. In contrast with the accepted passive release models suggested by the "danger hypothesis," it was recently shown that alarmins can also directly sense and report damage by signaling to the environment when released from live cells undergoing physiological stress, even without loss of subcellular compartmentalization. In this article, we review the involvement of alarmins such as IL-1α, IL-33, IL-16, and high-mobility group box 1 in cellular and physiological stress, and suggest a novel activity of these molecules as central initiators of sterile inflammation in response to nonlethal stress, a function we denote "stressorins." We highlight the role of posttranslational modifications of stressorins as key regulators of their activity and propose that targeted inhibition of stressorins or their modifiers could serve as attractive new anti-inflammatory treatments for a broad range of diseases.
Original language | English |
---|---|
Pages (from-to) | 1395-1402 |
Number of pages | 8 |
Journal | Journal of Immunology |
Volume | 198 |
Issue number | 4 |
DOIs | |
State | Published - 15 Feb 2017 |
Externally published | Yes |
Bibliographical note
Publisher Copyright:Copyright © 2017 by The American Association of Immunologists, Inc.
Funding
This work was supported by the Ministry of Aliya and Immigrant Asorption (I.C.); the Center for Absorption in Science, Israel (I.C.); the Israel Ministry of Science jointly with the Deutsches Krebsforschungscentrum, Heidelberg, Germany (R.N.A. and E.V.); the Israel Science Foundation supported by the Israel Academy of Sciences and Humanities (R.N.A. and E.V.); the Israel Cancer Association and the Israel Ministry of Health Chief Scientist's Office, 7th Framework Programme for Research and Technological Development: Cancer Inflammation (INFLA-CARE) (R.N.A. and E.V.); the Binational (Israel) Science Foundation (R.N.A. and E.V.); and the German-Israeli Foundation (R.N.A. and E.V.)
Funders | Funder number |
---|---|
7th Framework Programme for Research and Technological Development: Cancer Inflammation | |
Center for Absorption in Science, Israel | |
INFLA-CARE | |
Israel Ministry of Science | |
Ministry of Aliya and Immigrant Asorption | |
German Cancer Research Center | |
German-Israeli Foundation for Scientific Research and Development | |
United States-Israel Binational Science Foundation | |
Israel Academy of Sciences and Humanities | |
Israel Cancer Association | |
Israel Science Foundation | |
Office of the Chief Scientist, Ministry of Health |